These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24160438)

  • 1. Lipid nanocarriers and molecular targets for malaria chemotherapy.
    Jain K; Sood S; Gowthamarajan K
    Curr Drug Targets; 2014 Mar; 15(3):292-312. PubMed ID: 24160438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-facilitated drug delivery strategies in the treatment of plasmodium infection.
    Puttappa N; Kumar RS; Kuppusamy G; Radhakrishnan A
    Acta Trop; 2019 Jul; 195():103-114. PubMed ID: 31039335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug targets in malaria parasites.
    Padmanaban G
    Adv Biochem Eng Biotechnol; 2003; 84():123-41. PubMed ID: 12934935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology applied to the treatment of malaria.
    Santos-Magalhães NS; Mosqueira VC
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):560-75. PubMed ID: 19914313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobiotechnological modules as molecular target tracker for the treatment and prevention of malaria: options and opportunity.
    Anamika J; Nikhar V; Laxmikant G; Priya S; Sonal V; Vyas SP
    Drug Deliv Transl Res; 2020 Aug; 10(4):1095-1110. PubMed ID: 32378173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in targeting malaria with nanotechnology-based drug carriers.
    Rashidzadeh H; Tabatabaei Rezaei SJ; Adyani SM; Abazari M; Rahamooz Haghighi S; Abdollahi H; Ramazani A
    Pharm Dev Technol; 2021 Oct; 26(8):807-823. PubMed ID: 34190000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in use of silver nanoparticles as antimalarial agents.
    Rai M; Ingle AP; Paralikar P; Gupta I; Medici S; Santos CA
    Int J Pharm; 2017 Jun; 526(1-2):254-270. PubMed ID: 28450172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel molecular targets for antimalarial chemotherapy.
    Jana S; Paliwal J
    Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicines for Malaria Chemotherapy: Encapsulation vs. Polymer Therapeutics.
    Mvango S; Matshe WMR; Balogun AO; Pilcher LA; Balogun MO
    Pharm Res; 2018 Oct; 35(12):237. PubMed ID: 30324329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combating malaria with plant molecules: a brief update.
    Negi AS; Gupta A; Hamid AA
    Curr Med Chem; 2014; 21(4):458-500. PubMed ID: 24164201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug targets for resistant malaria: Historic to future perspectives.
    Kumar S; Bhardwaj TR; Prasad DN; Singh RK
    Biomed Pharmacother; 2018 Aug; 104():8-27. PubMed ID: 29758416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review.
    Mane UR; Gupta RC; Nadkarni SS; Giridhar RR; Naik PP; Yadav MR
    Expert Opin Ther Pat; 2013 Feb; 23(2):165-87. PubMed ID: 23228154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in antimalarial drug development.
    Vangapandu S; Jain M; Kaur K; Patil P; Patel SR; Jain R
    Med Res Rev; 2007 Jan; 27(1):65-107. PubMed ID: 16700012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunity in nanomedicine to counter the challenges of current drug delivery approaches used for the treatment of malaria: a review.
    Rajwar TK; Pradhan D; Halder J; Rai VK; Kar B; Ghosh G; Rath G
    J Drug Target; 2023 Apr; 31(4):354-368. PubMed ID: 36604804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies.
    Thakkar M; S B
    Drug Deliv Transl Res; 2016 Aug; 6(4):414-25. PubMed ID: 27067712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery.
    Marques J; Valle-Delgado JJ; Urbán P; Baró E; Prohens R; Mayor A; Cisteró P; Delves M; Sinden RE; Grandfils C; de Paz JL; García-Salcedo JA; Fernàndez-Busquets X
    Nanomedicine; 2017 Feb; 13(2):515-525. PubMed ID: 27720930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel molecular targets for antimalarial drug development.
    Sahu NK; Sahu S; Kohli DV
    Chem Biol Drug Des; 2008 Apr; 71(4):287-97. PubMed ID: 18298458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.